NOVN.Q Overzicht aandelen
NVN Liquidation, Inc., a medical dermatology company, focuses on developing and commercializing therapeutic products for skin diseases.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 2/6 |
| Toekomstige groei | 0/6 |
| Prestaties in het verleden | 0/6 |
| Financiële gezondheid | 0/6 |
| Dividenden | 0/6 |
NVN Liquidation, Inc. Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | US$0.000001 |
| 52 Week Hoogtepunt | US$1.38 |
| 52 Week Laag | US$0.000001 |
| Bèta | 1.65 |
| 11 maand verandering | -99.88% |
| 3 maanden verandering | -99.00% |
| 1 Jaar Verandering | -100.00% |
| 33 jaar verandering | -100.00% |
| 5 jaar verandering | -100.00% |
| Verandering sinds IPO | -100.00% |
Recent nieuws en updates
Recent updates
Take Care Before Diving Into The Deep End On Novan, Inc. (NASDAQ:NOVN)
Jun 07
Novan Q2 2022 Earnings Preview
Aug 10Novan pays off $16.5M in outstanding promissory note related to EPI Health acquisition
Jul 19Novan shares under pressure after proposing capital raise
Jun 16Novan’s NVN4100 shows antimicrobial effect against bacteria in animal health
Jun 07Novan: Q2 2021's SB206 Readout Is Life Or Death For This NO-Based Biotech
Apr 28Novan regains Nasdaq compliance for minimum bid price requirement
Jan 29Novan EPS in-line, beats on revenue
Oct 30Rendement voor aandeelhouders
| NOVN.Q | US Pharmaceuticals | US Markt | |
|---|---|---|---|
| 7D | -99.9% | -3.7% | -1.6% |
| 1Y | -100.0% | 17.2% | 30.8% |
Rendement versus industrie: NOVN.Q underperformed the US Pharmaceuticals industry which returned 11.6% over the past year.
Rendement versus markt: NOVN.Q underperformed the US Market which returned 22.3% over the past year.
Prijsvolatiliteit
| NOVN.Q volatility | |
|---|---|
| NOVN.Q Average Weekly Movement | 1,535.8% |
| Pharmaceuticals Industry Average Movement | 9.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 14.9% |
| 10% least volatile stocks in US Market | 2.9% |
Stabiele aandelenkoers: NOVN.Q's share price has been volatile over the past 3 months.
Volatiliteit in de loop van de tijd: NOVN.Q's weekly volatility has decreased from 1617% to 1536% over the past year, but is still higher than 75% of US stocks.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 2006 | 90 | Scott Plesha | www.novan.com |
NVN Liquidation, Inc. Samenvatting
| NOVN.Q fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | US$28.00 |
| Inkomsten(TTM) | -US$32.05m |
| Inkomsten(TTM) | US$24.92m |
0.0x
P/S-verhouding0.0x
Koers/WinstverhoudingIs NOVN.Q overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| NOVN.Q resultatenrekening (TTM) | |
|---|---|
| Inkomsten | US$24.92m |
| Kosten van inkomsten | US$24.45m |
| Brutowinst | US$473.00k |
| Overige uitgaven | US$32.52m |
| Inkomsten | -US$32.05m |
Laatst gerapporteerde inkomsten
Mar 31, 2023
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | -1.14 |
| Brutomarge | 1.90% |
| Nettowinstmarge | -128.61% |
| Schuld/Eigen Vermogen Verhouding | -1,164.1% |
Hoe presteerde NOVN.Q op de lange termijn?
Bekijk historische prestaties en vergelijking